Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Sol-Gel Technologies Ltd. (4SG.F)

0.5900
+0.1460
+(32.88%)
At close: April 23 at 12:59:42 PM GMT+2
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
11,707
1,554
3,883
31,272
8,771
Operating Expense
23,029
30,859
20,127
28,308
39,004
Operating Income
-11,322
-29,305
-16,244
2,964
-30,233
Net Non Operating Interest Income Expense
1,752
2,067
1,321
257
943
Pretax Income
-9,570
-27,238
-14,923
3,221
-29,290
Net Income Common Stockholders
-9,570
-27,238
-14,923
3,221
-29,290
Diluted NI Available to Com Stockholders
-9,570
-27,238
-14,923
3,221
-29,290
Basic EPS
-0.34
-1.01
-0.65
0.14
-1.30
Diluted EPS
-0.34
-1.01
-0.65
0.14
-1.30
Basic Average Shares
27,860.4520
27,087.0810
23,128.7220
23,063.4930
22,574.6880
Diluted Average Shares
27,860.4520
27,087.0810
23,128.7220
23,566.1820
22,574.6880
Total Operating Income as Reported
-11,322
-29,305
-16,244
2,964
-30,233
Total Expenses
23,029
30,859
20,127
28,308
39,004
Net Income from Continuing & Discontinued Operation
-9,570
-27,238
-14,923
3,221
-29,290
Normalized Income
-9,570
-27,238
-14,923
3,221
-29,290
Interest Income
1,752
2,067
1,321
257
943
Net Interest Income
1,752
2,067
1,321
257
943
EBIT
-11,322
-29,305
-16,244
2,964
-30,233
EBITDA
-11,322
-28,963
-15,682
3,844
-29,287
Reconciled Depreciation
--
342
562
880
946
Net Income from Continuing Operation Net Minority Interest
-9,570
-27,238
-14,923
3,221
-29,290
Normalized EBITDA
-11,322
-28,963
-15,682
3,844
-29,287
Tax Rate for Calcs
--
--
--
0.0002
--
12/31/2020 - 7/16/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CYCC Cyclacel Pharmaceuticals, Inc.
0.2302
+2.04%
 
GHRS GH Research PLC
9.50
+0.96%
 
FULC Fulcrum Therapeutics, Inc.
3.5900
-1.64%
 
CLSD Clearside Biomedical, Inc.
0.7955
-0.56%
 
ATAI Atai Life Sciences N.V.
1.5200
+3.40%
 
TPST Tempest Therapeutics, Inc.
7.89
+4.92%
 
CYBN Cybin Inc.
6.92
-1.84%
 
MNMD Mind Medicine (MindMed) Inc.
6.11
+5.34%
 
BEAM Beam Therapeutics Inc.
19.87
+3.87%
 
NTLA Intellia Therapeutics, Inc.
8.09
-2.65%